Lexicon Pharmaceuticals
LXRX
#6805
Rank
HK$6.07 B
Marketcap
HK$13.65
Share price
-4.40%
Change (1 day)
13.18%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Cash on Hand

Cash on Hand as of June 2026 : HK$1.49 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company has HK$1.49 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lexicon Pharmaceuticals - Cash on Hand chart (from 2000 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31HK$0.74 B-59.47%
2024-12-31HK$1.84 B39.12%
2023-12-31HK$1.32 B22.84%
2022-12-31HK$1.08 B59.82%
2021-12-31HK$0.67 B-42.7%
2020-12-31HK$1.18 B-44.2%
2019-12-31HK$2.11 B68.8%
2018-12-31HK$1.25 B-48.38%
2017-12-31HK$2.42 B-9.63%
2016-12-31HK$2.68 B-33.5%
2015-12-31HK$4.04 B53.52%
2014-12-31HK$2.63 B162.86%
2013-12-31HK$1.00 B-42.13%
2012-12-31HK$1.73 B-20.92%
2011-12-31HK$2.18 B33.17%
2010-12-31HK$1.64 B30.38%
2009-12-31HK$1.26 B58.14%
2008-12-31HK$0.79 B-60.51%
2007-12-31HK$2.01 B224.28%
2006-12-31HK$0.62 B-19.51%
2005-12-31HK$0.77 B13.6%
2004-12-31HK$0.68 B-15.62%
2003-12-31HK$0.80 B10.47%
2002-12-31HK$0.73 B-37.48%
2001-12-31HK$1.16 B-26.13%
2000-12-31HK$1.58 B2122.08%
1999-12-31HK$71.13 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Thermo Fisher Scientific
TMO
HK$31.88 B 2,032.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$9.06 B 505.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$62.73 B 4,094.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
HK$2.29 B 53.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$10.75 B 619.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
HK$1.22 B-18.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
HK$1.35 B-9.52%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$6.85 B 358.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
HK$39.45 M-97.36%๐Ÿ‡บ๐Ÿ‡ธ USA